PharmEasy acquires Aknamed in $180-$190 million stock deal
![](https://img.etimg.com/thumb/msid-86202005,width-1070,height-580,imgsize-42580,overlay-etmarkets/photo.jpg)
The acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based companys plans to position itself as a broader online healthcare firm, diversifying from being just an online medicine delivery platform.
via Economictimes
Post a Comment